160
Participants
Start Date
December 31, 2000
Primary Completion Date
February 28, 2005
fludarabine phosphate
Given IV
total-body irradiation
Undergo TBI
peripheral blood stem cell transplantation
Undergo PBSCT
allogeneic hematopoietic stem cell transplantation
Undergo PBSCT
cyclosporine
Given PO or IV
mycophenolate mofetil
Given IV or PO
laboratory biomarker analysis
Correlative studies
University of Torino, Torino
Baylor University Medical Center, Dallas
Huntsman Cancer Institute/University of Utah, Salt Lake City
LDS Hospital, Salt Lake City
University of Arizona Health Sciences Center, Tucson
City of Hope Medical Center, Duarte
Stanford University Hospitals and Clinics, Stanford
OHSU Knight Cancer Institute, Portland
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle
Froedtert Hospital, Milwaukee
Universitaet Leipzig, Leipzig
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Cancer Institute (NCI)
NIH
Fred Hutchinson Cancer Center
OTHER